Cover Image

Rapid disease progression on immune checkpoint inhibitors in young patients with stage IV melanoma

Show other versions (1)

BackgroundImmune checkpoint inhibitors (ICIs) are the standard of care for metastatic cutaneous melanoma (mCM) patients, but their efficacy in young adults aged less than 40 years remains unclear.Materials and methodsWe retrospectively analyzed 303 stage IV melanoma patients of different ages treate...

Full description

Saved in:
Bibliographic Details
Main Authors: Machiraju, Devayani (Author) , Schäfer, Sarah (Author) , Beckhove, Philipp (Author) , Roth, Jasmin (Author) , Schulz, Carsten (Author) , Hassel, Jessica C. (Author)
Format: Article (Journal)
Language:English
Published: 23 January 2023
In: Frontiers in medicine
Year: 2023, Volume: 10, Pages: 1-7
ISSN:2296-858X
DOI:10.3389/fmed.2023.1117816
Online Access:Resolving-System, kostenfrei, Volltext: https://doi.org/10.3389/fmed.2023.1117816
Verlag, kostenfrei, Volltext: https://www.frontiersin.org/articles/10.3389/fmed.2023.1117816
Get full text
Author Notes:Devayani Machiraju, Sarah Schäfer, Philip Beckhove, Jasmin Roth, Carsten Schulz and Jessica C. Hassel
Search Result 1
Cover Image

Circulating interleukin-4 is associated with a systemic T cell response against tumor-associated antigens in treatment-naïve patients with resectable non-small-cell lung cancer by Safi, Seyer (Author) , Yamauchi, Yoshikane (Author) , Hoffmann, Hans (Author) , Weichert, Wilko (Author) , Jost, Philipp J. (Author) , Winter, Hauke (Author) , Muley, Thomas (Author) , Beckhove, Philipp (Author) ,


Get full text
Article (Journal) Online Resource

Saved in:
Show all versions (2)

Similar Items